Spanish plasma-derived medicines specialist Grifols revealed it is collaborating with Dutch biotechnology start-up, FcR ...

Grifols, a global healthcare company and leading manufacturer of plasma-derived medicines, has announced a collaboration with ...

For decades, Grifols grew rich from an empire built on blood. Founded by a plucky scientist and his two sons in the years after the Spanish Civil War, the company made a series of breakthroughs that ...

Spanish drugmaker Grifols has been awarded a $21 million grant ... and the MJFF donation will help accelerate that work in the Parkinson's arena. At the moment, doctors use a combination of ...

Activist short seller Nate Anderson is going out ‘on top’, according to one rival, as difficulties for short sellers mount in a relentless bull market.

(Bloomberg) -- Drugmaker Grifols SA and US short seller Gotham City Research are counting on two different reports from a Spanish regulator to bolster their cases as they prepare to face off in ...

Grifols has filed for US approval of a new drug for rare bleeding disorder acquired fibrinogen deficiency (AFD), which promises to provide a more reliable and easier treatment for patients.

Your physical environment, social life and lifestyle have as much an influence on your biology − and hence, how you process ...

WorkTango used Deloitte survey data and more to analyze how millennial and Gen Z workers are responding to artificial ...

Despite its transformative potential, purpose can feel inaccessible to many. According to McKinsey research, 85% of executives report feeling a strong sense of purpose in their work, compared to just ...